Skip to content
value.today

Urovant Sciences

UROVUnlisted company
$512 Mlast known market cap, Jan 2021 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

About Urovant Sciences

Urovant Sciences is a Biopharmaceutical company focused on developing and commercializing innovative therapies for a range of urologic conditions. The company estimated annual revenue is currently 39.2 million USD per year. The headquarters is in USA.

More about Urovant Sciences

Acquisitions and changes
No longer listed: ticker UROV is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$138 M$276 M$415 M$553 M20202021

World rank over time

▲ up 364 places since 2020
2020-01-01: #11400#11,40020202021-01-01: #11036#11,0362021

Rank in USA: #2,536 (Jan 2020) · #2,731 (Jan 2021)

Lobbying by Urovant Sciences#

$70 K spent on lobbying the US Congress and federal agencies in 2020, most often on health issues and budget/appropriations.

Lobbying, 2020
$70 K
#1,092 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
1
in 2020
2026 so far
—
  • Health Issues3 reports
  • Budget/Appropriations1 report

Lobbying firms hired in 2020

Forbes-Tate $70 K

Urovant Sciences: lobbying spending by year
YearSpendingOwn lobbyistsReports
2020$70 K—3

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Urovant Sciences”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

H-1B hiring at Urovant Sciences#

1 labor condition applications certified in fiscal 2021 for 1 positions, at a median wage of $235 K a year.

Certified, FY2021
1
#1,890 among companies on value.today
Worker positions
1
Median wage offered
$235 K
a year, full-time
Applications filed
1
Urovant Sciences: most frequent H-1B job titles in fiscal 2021
Job titlePositionsMedian wage offered
Senior Director, Pricing, Contracts & AnalyticsMarketing Managers1$235 K

Where: Irvine, CA 1

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Urovant Sciences, Inc

Layoffs at Urovant Sciences#

From US state WARN notices and SEC 8-K restructuring filings, newest first.

People, last 12 months
0
0 notices and filings
People, all years
23
2023–2023
Latest
1 person
2023-05-23
Urovant Sciences: people laid off by year and month
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2023···221·······23
Urovant Sciences: latest layoffs
AnnouncedPeopleKindWhereSource
effective 1 personLayoffWARN noticeIrvine, CaliforniaNotice list
effective 22 peopleLayoffWARN noticeIrvine, CaliforniaNotice list

Source: State WARN notices and SEC 8-K item 2.05

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Urovant Sciences🇺🇸$512 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 1, 2021 (last known)
Profile updated:
Nov 14, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Urovant Sciences? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Urovant Sciences's ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Urovant Sciences? Suggest a correction